Pharmacokinetic Studies in Healthy Subjects for the Development of an Extended-Release Tablet Formulation of Guaifenesin: A 505(b)(2) New Drug Application Approval
2013 ◽
Vol 2
(1)
◽
pp. 25-32
◽